Cancer risk in systemic lupus: An updated international multi-centre cohort study

Medicine and Dentistry

• Cancer Risk 100%
• Cohort Analysis 100%
• Hematologic Malignancy 10%
• Leukemia 10%
• Lupus Erythematosus 100%
• Malignant Neoplasm 80%
• Neoplasm 10%
• Non-Hodgkin Lymphoma 10%
• Ovarian Cancer 20%
• Population 20%
• Standardized Incidence Ratio 100%
• Systemic Lupus Erythematosus 30%
• Thyroid Gland 20%
• Vulva 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Hematologic Malignancy 10%
• Leukemia 10%
• Malignant Neoplasm 80%
• Neoplasm 10%
• Nonhodgkin Lymphoma 10%
• Ovary Cancer 20%
• Standardized Incidence Ratio 100%
• Systemic Lupus Erythematosus 30%

Keyphrases

• Exogenous Factors 10%
• Tumor Registry 10%